Hyperinflammation and Hyperferritinemia in Critically Ill Patients
NCT ID: NCT06820905
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1962 participants
OBSERVATIONAL
2025-02-20
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Anemia Associated Parameters in Septic Patients
NCT04281888
Hepcidine and Iron Deficiency in Critically Ill Patients
NCT02276690
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
NCT04094428
Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin
NCT01530932
Oxidative Monitoring in ICU Patients.
NCT02114853
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
critically ill patients
critically ill patients admitted to ICU between 01.01.2020 and 31.12.2024
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admission between 01.01.2020 and 31.12.2024 (5yrs)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Karvunidis
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Karvunidis, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine and Teaching Hospital, Charles University, Pilsen, Czech Republic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine and Teaching Hospital, Charles University
Pilsen, Czech Republic, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYFER_2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.